Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium - PubMed (original) (raw)

Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium

A Slungaard et al. J Exp Med. 1990.

Abstract

Eosinophils (EOs) participate in a variety of inflammatory states characterized by endothelial cell damage, such as vasculitis, pneumonitis, and endocarditis. We find that 100 U/ml TNF-alpha/cachectin (TNF), a concentration attainable in the blood of humans with parasitic infestations, stimulates highly purified populations of EOs to damage human umbilical vein endothelial cells (HUVEC), a model of human endothelium. This TNF-dependent EO cytotoxicity is strongly inhibited by heparin and methyprednisolone but unaffected by the platelet-activating factor antagonist BN52012 or scavengers of superoxide anion and H2O2, superoxide dismutase and catalase. However, addition of a physiologically relevant concentration of Br- (100 microM) enhances EO/TNF damage to HUVEC, implicating the possible participation of EO peroxidase (EPO) in the killing mechanism. EOs adherent to FCS-coated plastic wells more than double their production of superoxide anion and the cytotoxic EPO-derived oxidant HOBr when exposed to TNF, showing that TNF activates the respiratory burst of EOs attached to a "physiologic" surface. Unlike PMNs, EOs were not irreversibly activated to kill unopsonized endothelium by previous exposure to TNF, and did not degranulate or upregulate CR3 expression as detected by Mo1 in the presence of 100 U/ml TNF. HUVEC exposed 18 h to TNF were considerably more susceptible to lysis by PMA-activated EOs and reagent H2O2, demonstrating a direct effect of TNF upon endothelium, perhaps through inhibition of antioxidant defenses. These findings suggest that abnormally elevated serum levels of TNF may provoke EOs to damage endothelial cells and thereby play a role in the pathogenesis of tissue damage in hypereosinophilic states.

PubMed Disclaimer

Cited by

Bromide-dependent toxicity of eosinophil peroxidase for endothelium and isolated working rat hearts: a model for eosinophilic endocarditis.
Slungaard A, Mahoney JR Jr. Slungaard A, et al. J Exp Med. 1991 Jan 1;173(1):117-26. doi: 10.1084/jem.173.1.117. J Exp Med. 1991. PMID: 1985118 Free PMC article.
Differential regulation of TNF-alpha and IL-1beta production from endotoxin stimulated human monocytes by phosphodiesterase inhibitors.
Molnar-Kimber KL, Yonno L, Heaslip RJ, Weichman BM. Molnar-Kimber KL, et al. Mediators Inflamm. 1992;1(6):411-7. doi: 10.1155/S0962935192000620. Mediators Inflamm. 1992. PMID: 18475493 Free PMC article.
Tumour necrosis factor-alpha in nasal allergy.
Hisamatsu K, Ganbo T, Nakazawa T, Nakajima T, Ko J, Goto R, Murakami Y, Misui K. Hisamatsu K, et al. Mediators Inflamm. 1995;4(5):368-73. doi: 10.1155/S0962935195000603. Mediators Inflamm. 1995. PMID: 18475667 Free PMC article.
Differential oxidative stress gene expression profile in mouse brain after proton exposure.
Baluchamy S, Zhang Y, Ravichandran P, Ramesh V, Sodipe A, Hall JC, Jejelowo O, Gridley DS, Wu H, Ramesh GT. Baluchamy S, et al. In Vitro Cell Dev Biol Anim. 2010 Sep;46(8):718-25. doi: 10.1007/s11626-010-9330-2. Epub 2010 Jul 7. In Vitro Cell Dev Biol Anim. 2010. PMID: 20607620
Eosinophils in the 1990s: new perspectives on their role in health and disease.
Wardlaw AJ. Wardlaw AJ. Postgrad Med J. 1994 Aug;70(826):536-52. doi: 10.1136/pgmj.70.826.536. Postgrad Med J. 1994. PMID: 7937446 Free PMC article. Review.

References

1. Br Heart J. 1977 Mar;39(3):233-7 - PubMed
1. Blood. 1989 Sep;74(4):1374-80 - PubMed
1. Am J Med. 1979 Oct;67(4):572-82 - PubMed
1. J Clin Invest. 1981 Jan;67(1):28-36 - PubMed
1. J Clin Invest. 1981 Jan;67(1):93-102 - PubMed

Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium - PubMed (original) (raw)